FDA Grants Soterix Medical IDE Approval for Home-based tDCS-LTE Trial for Depression https://t.co/6uF1E5YsuW The trial is open to patients for whom access to rTMS or ECT therapy has been limited due to the #COVID19 pandemic. If you think you qualify, please contact us #depression
Press articles discussing the HD-tACS study on working memory revival: nytimes-https://t.co/irlhWiRJ8g science alert- https://t.co/BgIC8JjZPB NPR-https://t.co/e26mOSveA9 Ars Technica-https://t.co/NcSByqNvr3 #neuromodulation#HDtACS#aging#memory#HDtES
#HDtDCS of LDLPFC indicates that focalized,unilateral stimulation may change performance during risky tasks and diminish risky decision making https://t.co/eifidwblfy Learn more about High Definition tES here https://t.co/Ck1wLzrglX #tDCS#neuromodulation
Inphase/antiphase HD-tACS of medial frontal cortex (MFC) and right lateral prefrontal cortex (lPFC) https://t.co/qzebfAS4Hi using MxN HD system https://t.co/F83UlTii4T #HDtACS#neuromodulation@SoterixMedical